Healthcare Sector in India Monthly Update May 2013
-
Upload
researchonglobalmarketscom -
Category
Documents
-
view
213 -
download
0
Transcript of Healthcare Sector in India Monthly Update May 2013
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 1/12
Healthcare Sector in India
Monthly Update
May 2013
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 2/12
Healthcare – Monthly Update
Top Story
India
gets
its
1st
ever
indigenous
rotavirus
vaccine
India’s 1st completely indigenous and affordable rotavirus diarrhoea vaccine has been
introduced after 28 years of hard work. The results of the Phase III clinical trial of the
Rotavac vaccine was announced at an international conference that declared efficiency level
at 56% in the 1st year of life. The oral vaccination is administered to infants in a 3 dose
course at the ages of 6, 10 and 14 weeks alongside routine immunizations recommended at
these ages.
Commercial production of the same will be initiated after it gets clearance from Drug
Controller General of India (DCGI). Hyderabad based Bharat Biotech International Ltd. which
was associated in the development of vaccine candidates and clinical trials has declared a
price of approximately INR 53.92, a relatively much lower price than other rotavirus vaccinescurrently available in the market.
News Update
General
USFDA endows approval for 2 drugs to Aurobindo Pharma
Hyderabad based Aurobindo Pharma Ltd. has garnered the approval of United States Food
and Drug Administration (USFDA) to manufacture and market 2 drugs. One being, thegeneric version of Boehringer Ingelheim Pharmaceuticals' manufactured Flomax
(Tamsulosin hydrochloride) capsule used for treatment of symptoms of enlarged prostate in
men. The other being generic version of Pharmacia & Upjohn's Cleocin Pediatric
(Clindamycin Palmitate Hydrochloride) used for treatment of serious infections caused by
susceptible anaerobic bacteria in minors.
The products are expected to be launched soon and would thereby add to Aurobindo
Pharma’s Abbreviated New Drug Application (ANDA) approvals from USFDA to 190.
GSK verticals brandsswap
GlaxoSmithKline Consumer Healthcare has signed a brandsswap deal with its associatecompany GSK Pharmaceuticals with a motive to reach its revenue target in the next 3 years.
The companies have agreed to interchange select brands and independently market, sell and
distribute them. The companies will initiate the agreement with GSK Consumer marketing
and selling GSK Pharma's OTC calcium and vitamin supplement Ostocalcium. On the other
hand, GSK Pharma will market and distribute products under the consumer division's
specialized arm Glaxo Nutrition including Actibase and Actigrow nutrition supplements.
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 3/12
Healthcare – Monthly Update
The companies have strategically decided to stimulate its product distribution by making use
of their respective negotiation strengths.
Kolkata gets
its
1st
super
-specialty
mental
health
facility
The 1st ever super‐specialty mental health facility Addlife Caring Minds has been launched in
Kolkata. Some of the services offered include psychotherapy, counseling and treatment along
with psych‐social rehabilitation and follow‐up services.
The hospital is located over a 4,000 square feet area and has corporate clients such as
Ambuja Realty, Patton and Kolkata Police among others.
Biocon and Trinity collaborate to encourage genetic research
Bengaluru based Biocon has entered into a partnership with Dublin‐based Trinity College to
support Indian students in genetic research. Biocon will sponsor two annual sponsorships
that would give meritorious candidates an opportunity to work in Trinty Collegelaboratories.
The sponsorship program has been especially designed to encourage innovation in the field
of biotechnology.
GE launches healthcare technology lounge on wheels GE Healthcare has very recently launched its 1st healthcare technology experiential lounge
on wheels under its Mission Healthier India in Coimbatore. The entire set up has been built at
a cost of INR 4 mn that comprises of equipment such as ECG, scan, critical tools and infant
care technologies. The mission was focused at development of women and maternal infant
health, cardiac diseases and critical care in small towns and villages of Tamil Nadu.
With launch of this lounge, GE is aggressively promoting the technology at hospitals, nursing
homes and clinics in 50 towns of Tamil Nadu to raise awareness about the significance of
early detection of diseases.
News Update
Regulatory
Virology labs in Tamil Nadu government medical colleges Tamil Nadu state government would be soon establishing Molecular Virology Laboratories in
Medical College Hospitals in Chennai, Madurai, Coimbatore and Tirunelveli. An allocation of
INR 200 mn has been made for each of the laboratories and in time would be replicated in all
other medical college hospitals in the state. The laboratory is being set up primarily to avoid
delay in diagnosis of diseases such as Dengue, Chickungunya and swine flu.
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 4/12
Healthcare – Monthly Update
Apart from an investment on laboratory, Tamil Nadu government is also allocating funds for
improvement of the state’s Indian Medicine. Lifestyle clinics are also in plans to be set up for
treatment of blood pressure, diabetes, heart diseases, cancer and backbone related ailments.
New government hospital to be launched in South Delhi The Delhi state government is in plans to establish a 200‐bedded hospital on a fast‐track
basis at AmbedkarNagar area of Southern Delhi. The hospital would have OPD, general
wards, separate mother and child care wards, advanced laboratory, a blood bank and
intensive care units.
The state government has completed the basic outlay of the project and hospital construction
is expected to commence in Sep 2013.
GE, Ensocare signs agreement with Maharashtra government to establish advanced
diagnostic centers
Wipro GE Healthcare and Ensocare (of Enso Group) have collaborated to form a public
private partnership (PPP) with Maharashtra state government for establishing advanced
diagnostic facilities in the state. The agreement will see the establishment of diagnostic
facilities at 22 government district and women hospitals.
The diagnostic facilities will be offering services at government recommended rates with
additional benefits for 'Below Poverty Line' (BPL) card holders who will be offered free
diagnostic services under the Rajiv Gandhi Jeevandayee Arogya Yojana (RGJAY) scheme.
News Update
Expansion Plans
Star Dental plans expansion
Star Dental is in plans to invest INR 1,500 mn in the next 3 years time to expand operations
across the country. It is in plans to open 300 clinics across India by 2017 of which 40 of them
would be company owned clinics. The company owned clinics is expected to be launched by
2014.
The dental chain that initiated operation in 2012 in India set up 11 clinics across DelhiNational Capital Region (NCR) under the brand name 'Clove' and with the round of fresh
investments, it would most likely focus on North India, including NCR and Punjab.
HCG stake purchase in BACC to aid fertility centers’ expansion
Bengaluru based cancer care provider HealthCare Global Enterprises has acquired a majority
stake in fertility care provider Bangalore Assisted Conception Centre (BACC). With this stake
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 5/12
Healthcare – Monthly Update
purchase, the 4 fertility centers across Bengaluru that were previously independently
operated have been rebranded as Milann ‐ The Fertility Center.
The new entity is expected to expand in other towns and cities including tier II and tier IIItowns. The Indian fertility market is gradually garnering significance with more investors
taking interest.
Industry Expert Speak
GE, Ensocare signs agreement with Maharashtra government to establish advanced
diagnostic centers – John Rice, Vice Chairman - GE
"Through progressive public private partnerships, like the one we are announcing today with
the Government of Maharashtra, patients are the biggest winners as they'll have access to
advanced and affordable healthcare that previously wasn't available to them."
GSK verticals brandsswap – Zubair Ahmed, Managing Director– GSK Consumer
Healthcare
"We are banking on innovation, close collaboration with GSK Pharma, rural thrust and
accelerating our base business. We will collaborate to leverage each other's assets in more
than one ways."
Transactions (Feb 2013 – Apr 2013)
Date Buyer Target Deal Size
(INR mn) % stake Deal Status
Type of
Transaction
24th May
2013
Villgro
Innovations
Foundation
Windmill
Health
Technologies
N.A. N.A. Completed Private Equity
28th May
2013
Navam Capital
and
Aarin Capital
Invictus
Oncology Pvt.
Ltd.
105 N.A. Completed Private Equity
23rd May
2013
Gavis Pharma
LLCWintac Ltd N.A. 26% Planned Private Equity
15th May
2013
Manipal
Health
Enterprises
Ankur
Healthcare
(Manipal
Ankur
Andrology and
400 N.A. Planned M&A
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 6/12
Healthcare – Monthly Update
Reproductive
Services)
13th May
2013
Goldman
Sachs
BPL Medical
Technologies 1,100 N.A. Planned Private Equity
9th May
2013
International
Finance
Corporation
Ravindranath
GE Medical
Associates Pvt.
Ltd.
1,340 N.A. Completed Private Equity
3rd May
2013
Smith &
Nephew Plc.
Adler
Mediequip Pvt.
Ltd.
N.A. N.A. Completed M&A
25th Apr
2013
International
Finance
Corporation
Fortis
Healthcare Ltd.542 6 Planned Private Equity
23rd Apr
2013
Somerset
Indus Capital
Partners
Cygnus
Medicare Pvt.
Ltd.
N.A. N.A. Completed Private Equity
16th Apr
2013
Fulcrum
Venture India
Shield
Healthcare Pvt.
Ltd.
218.2 N.A. Completed Private Equity
15th Apr
2013
Seedfund
&
Asian
Healthcare
Fund
Total Dental
Care Pvt. Ltd.500 N.A. Completed Private Equity
12th Apr
2013
Singapore
based investor
AmrishOncology
Services Pvt.
Ltd.
330 N.A. Completed Private Equity
12th Apr
2013
OrbiMed
Advisors
Claris
Lifesciences
Ltd.
2,013.04 N.A. Completed Private Equity
2nd Apr
2013
India Venture
Advisors
Global Baroda
HospitalN.A. N.A. Completed Private Equity
1st Apr
2013
Mortara
Instruments
Inc
Cardiac Science 1,140 N.A. Planned M&A
25th Mar
2013ChrysCapital
Ipca
Laboratories
Ltd.
2,174 4 Completed Private Equity 22nd Mar
2013
Jacob Ballas
Capital India
Pvt. Ltd.
Vivimed Labs
Ltd.670 13.1 Completed Private Equity
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 7/12
Healthcare – Monthly Update
22nd Mar
2013
Quadria
Capital
Milestone
Religare
Investment
Advisors Pvt.
Ltd.
N.A. 100 Completed Private Equity
20th Mar
2013
Intel and
Sequoia
Capital
Healthkart 760 N.A. Completed Private Equity 15th Mar
2013
Fresenius Kabi
India Pvt. Ltd.
Parenteral
Drugs India
Ltd.
2,000 N.A. Completed M&A
13th Mar
2013Route One Strides Arcolab 558.1 N.A. Completed Private Equity
11th Mar
2013
Temasek
Holdings
Healthcare
Global
Enterprises
(HCG)
1,400 N.A. Completed Private Equity 2nd Mar
2013IFC Hikal Ltd. 435 N.A. Planned Private Equity
Annual Financial Results – Revenue (INR mn)
Companies FY ‘10 FY ‘11 FY ‘12 FY ‘13
Ajanta Pharma Ltd. 4091.43 4988.30 6773.97 9,201.40
Alembic Ltd. 11399.17 2019.30 1168.73 1,723.50
Apollo Hospitals Enterprise
Ltd.20264.65 26053.50 31475.25 37,687.10
AstraZeneca Pharma India Ltd. 4673.48 5017.41 5312.80 3,902.50
Biocon Ltd. 23,932.70 27,947.70 21,483.00 24,276.00
Cipla Ltd. 56,704.00 63,850.70 68,477.00 82,793.30
Divi's Laboratories Ltd. 9499.23 13145.32 18611.42 21,399.00
Dr. Reddy's Laboratories Ltd. 70,277.00 74,693.00 96,737.40 116,265.60
Glenmark Pharmaceuticals
Ltd.25,291.30 29,490.70 40,206.40 50,123.40
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 8/12
Healthcare – Monthly Update
Hikal Ltd. 5389.52 5022.95 7078.11 6,604.20
Jubilant Life Sciences Ltd. 38,047.80 34,484.40 42,539.50 51,429.90
Lupin Ltd. 48,318.10 57,851.90 70,829.10 94,616.30
Novartis India Ltd. 6546.77 7512.10 8442.90 8,861.00
Pfizer Ltd. N.A. 8132.12 9588.99 10,500.70
Piramal Enterprises Ltd. 36,276.30 25,157.70 20,838.30 34,959.40
Piramal Life Sciences Ltd. 62.10 158.10 28.50 52.40
Span Diagnostics Ltd. 802.61 840.05 607.06 814.90
Sun Pharmaceutical Industries
Ltd.38,086.30 57,214.30 80,056.60 112,998.60
Vimta Labs Ltd. 868.02 957.01 873.45 1,091.00
Wockhardt Ltd. 36,477.60 37,633.50 46,138.00 56,094.20
* Change in Financial Year Ending
Annual Financial Results – Income (INR mn)
Companies FY ‘10 FY ‘11 FY ‘12 FY ‘13
Ajanta Pharma Ltd. 340.04 507.13 772.66 1121.10
Alembic Ltd. 395.38 ‐129.02 ‐121.98 114.90
Apollo Hospitals Enterprise
Ltd.1375.68 1839.22 2193.46 3043.50
AstraZeneca Pharma India Ltd. 557.76 615.16 197.65 ‐895.32
Biocon Ltd. 2932.44 3675.00 3384.00 5088.20
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 9/12
Healthcare – Monthly Update
Cipla Ltd. 10825.90 9895.70 11442.40 15448.50
Divi's Laboratories Ltd. 3403.37 4292.69 5332.64 6020.10
Dr. Reddy's Laboratories Ltd. 1068.00 11040.00 14262.00 16777.40
Glenmark Pharmaceuticals
Ltd.3244.71 4532.08 4603.48 6147.43
Hikal Ltd. 72.89 370.21 460.34 252.50
Jubilant Life Sciences Ltd. 4214.61 2297.19 145.61 1527.30
Lupin Ltd. 6816.30 8625.50 8676.50 13141.60
Novartis India Ltd. 1159.89 1466.70 1520.20 1197.30
Pfizer Ltd. N.A. 1697.56 1846.06 5032.00
Piramal Enterprises Ltd. 4819.00 128833.60 1115.00 ‐2272.90
Piramal Life Sciences Ltd. ‐1297.90 ‐1429.80 ‐71.10 ‐63.60
Span Diagnostics Ltd. 54.53 54.84 10.32 3.12
Sun Pharmaceutical IndustriesLtd.
13510.80 18160.60 25872.50 30080.60
Vimta Labs Ltd. 26.59 ‐46.65 ‐153.76 42.13
Wockhardt Ltd. ‐9804.23 905.20 3427.10 15941.20
* Change in Financial Year Ending
Quarterly Financial
Results
– Revenue
(INR
mn)
Companies Apr-Jun
2012
Jul-Sep
2012
Oct -Dec
2012
Jan-Mar
2013
Ajanta Pharma Ltd. N.A. N.A. N.A. N.A.
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 10/12
Healthcare – Monthly Update
Alembic Ltd. 253.40 318.80 729.40 421.90
Apollo Hospitals Enterprise
Ltd.
N.A. N.A. N.A. N.A. AstraZeneca Pharma India Ltd. 952.40 992.30 1,049.10 948.50
Biocon Ltd. 5,770.00 5,924.00 6,342.20 6,301.20
Cipla Ltd. N.A. N.A. N.A. N.A. Divi's Laboratories Ltd. N.A. N.A. N.A. 6,558.30
Dr. Reddy's Laboratories Ltd. 25,406.00 28,809.00 28,651.00 33,399.40
Glenmark Pharmaceuticals
Ltd.10,404.10 12,551.90 13,812.60 13,354.90
Hikal Ltd. N.A. N.A. N.A. N.A. Jubilant Life Sciences Ltd. 12,358.90 12,197.30 13,018.10 13,882.90
Lupin Ltd. 22,191.50 22,392.60 24,658.70 25,373.50
Novartis India Ltd. 2,195.20 N.A. 2,335.40 2,082.10
Pfizer Ltd. 837,545.60 738,771.40 N.A. 732,982.50
Piramal Enterprises Ltd. 7,472.40 8,630.30 9,935.70 9,269.30
Piramal Life Sciences Ltd. 16.40 7.70 16.50 8.80
Span Diagnostics Ltd. 151.87 254.58 202.40 204.09
Sun Pharmaceutical Industries
Ltd.26,581.40 26,638.60 28,520.10 30,714.90
Vimta Labs Ltd. 263.850 276.49 265.38 285.30
Wockhardt Ltd. 14,258.20 13,474.40 14,350.40 14,855.00
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 11/12
Healthcare – Monthly Update
Quarterly Financial Results – Income (INR mn)
Companies
Apr-Jun
2012
Jul-Sep
2012
Oct -Dec
2012
Jan-Mar
2013
Ajanta Pharma Ltd. N.A. N.A. N.A. N.A.
Alembic Ltd. ‐39.30 12.30 102.50 39.60
Apollo Hospitals Enterprise
Ltd.N.A. N.A. N.A. N.A.
AstraZeneca Pharma India Ltd. ‐266.30 ‐451.20 ‐177.00 ‐185.80
Biocon Ltd. 790.00 896.50 917.60 2,486.10
Cipla Ltd. N.A. N.A. N.A. N.A.
Divi's Laboratories Ltd. N.A. N.A. N.A. 1,805.70
Dr. Reddy's Laboratories Ltd. 3,360.00 3,925.00 3,782.00 5,710.10
Glenmark Pharmaceuticals
Ltd.782.80 1,567.50 2,129.20 1,668.00
Hikal Ltd. N.A. N.A. N.A. N.A.
Jubilant Life Sciences Ltd. 50.10 1,520.00 266.90 ‐309.70
Lupin Ltd. 2,803.90 2,904.60 3,352.30 4,080.80
Novartis India Ltd. 269.80 N.A. 290.00 244.10
Pfizer Ltd. 180,948.10 169,574.90 N.A. 149,311.30
Piramal Enterprises Ltd. 40.80 ‐920.20 610.70 ‐2,004.10
Piramal Life Sciences Ltd. ‐15.40 ‐26.90 ‐13.30 ‐9.70
Span Diagnostics Ltd. ‐7.97 22.96 ‐9.01 0.92
Sun Pharmaceutical Industries
Ltd.7,955.50 3,196.40 8,813.00 10,115.60
Vimta Labs Ltd. 4.81 8.86 12.35 16.12
7/28/2019 Healthcare Sector in India Monthly Update May 2013
http://slidepdf.com/reader/full/healthcare-sector-in-india-monthly-update-may-2013 12/12
Healthcare – Monthly Update
Wockhardt Ltd. 3,779.70 4,535.50 4,278.40 3,347.60
Research on India (ROI) is a leading source for market research on various sectors in India
that offers premium research content from worldwide publishers of market research
reports.
Contact us:
W: www.researchonindia.com
T: India (Toll Free): 1800 102 1133; International: +91 (33) 4027 6214/5
Connect with Us
Disclaimer: This monthly update is published for general information only based on press articles and company releases. Research on India has not independently verified any of information and is not responsible for any loss or damage arising from use of this document.
Events Calendar
Sustainable Strategies for a Healthy India:
Imperatives for Consolidating the Healthcare
Management Ecosystem
Date: 18th Jun 2013
Venue: Taj West End
City: Bengaluru, Karnataka
Organizer: All India Management Association
(AIMA)Contact No: +91 11 24645100
Website: www.aima.in
3rd National Conference of Academy of
Regional Anaesthesia of India
Date: 7th to 9th Jun 2013
Venue: Smt. Kashibai Navale Medical College and
General Hospital
City: Pune, Maharashtra
Contact Person: Dr. Sandeep Diwan
Organizer: AORA India and Shrimati KashibaiNavale Medical College and General Hospital
Contact No: 9823029328
E‐ Mail: [email protected]
Website: aoraindia2013.com